These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 28881011)
1. Sarcolemmal excitability in the myotonic dystrophies. Boland-Freitas R; Lee J; Howells J; Liang C; Corbett A; Nicholson G; Ng K Muscle Nerve; 2018 Apr; 57(4):595-602. PubMed ID: 28881011 [TBL] [Abstract][Full Text] [Related]
2. In vivo assessment of muscle membrane properties in myotonic dystrophy. Tan SV; Z'graggen WJ; Boërio D; Turner C; Hanna MG; Bostock H Muscle Nerve; 2016 Aug; 54(2):249-57. PubMed ID: 26789642 [TBL] [Abstract][Full Text] [Related]
3. Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes. Santoro M; Piacentini R; Masciullo M; Bianchi ML; Modoni A; Podda MV; Ricci E; Silvestri G; Grassi C Neuropathol Appl Neurobiol; 2014 Jun; 40(4):464-76. PubMed ID: 23888875 [TBL] [Abstract][Full Text] [Related]
4. Sarcolemmal excitability changes in normal human aging. Lee JHF; Boland-Freitas R; Ng K Muscle Nerve; 2018 Jun; 57(6):981-988. PubMed ID: 29314071 [TBL] [Abstract][Full Text] [Related]
5. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1? Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604 [TBL] [Abstract][Full Text] [Related]
6. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients. Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234 [TBL] [Abstract][Full Text] [Related]
11. In vivo assessment of muscle membrane properties in the sodium channel myotonias. Tan SV; Z'Graggen WJ; Hanna MG; Bostock H Muscle Nerve; 2018 Apr; 57(4):586-594. PubMed ID: 28877545 [TBL] [Abstract][Full Text] [Related]
12. Does quantitative EMG differ myotonic dystrophy type 2 and type 1? Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913 [TBL] [Abstract][Full Text] [Related]
13. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2). Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272 [TBL] [Abstract][Full Text] [Related]
14. Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2. Pisani V; Panico MB; Terracciano C; Bonifazi E; Meola G; Novelli G; Bernardi G; Angelini C; Massa R Muscle Nerve; 2008 Nov; 38(5):1405-1411. PubMed ID: 18816606 [TBL] [Abstract][Full Text] [Related]
15. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 and DM2). Gawel M; Szmidt-Salkowska E; Lusakowska A; Nojszewska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM Muscle Nerve; 2014 Feb; 49(2):277-83. PubMed ID: 23716346 [TBL] [Abstract][Full Text] [Related]
16. Force training induces changes in human muscle membrane properties. Z'Graggen WJ; Trautmann JP; Bostock H Muscle Nerve; 2016 Jun; 54(1):144-6. PubMed ID: 27104654 [TBL] [Abstract][Full Text] [Related]
17. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. Vihola A; Bachinski LL; Sirito M; Olufemi SE; Hajibashi S; Baggerly KA; Raheem O; Haapasalo H; Suominen T; Holmlund-Hampf J; Paetau A; Cardani R; Meola G; Kalimo H; Edström L; Krahe R; Udd B Acta Neuropathol; 2010 Apr; 119(4):465-79. PubMed ID: 20066428 [TBL] [Abstract][Full Text] [Related]
18. SCN4A as modifier gene in patients with myotonic dystrophy type 2. Binda A; Renna LV; Bosè F; Brigonzi E; Botta A; Valaperta R; Fossati B; Rivolta I; Meola G; Cardani R Sci Rep; 2018 Jul; 8(1):11058. PubMed ID: 30038349 [TBL] [Abstract][Full Text] [Related]
19. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537 [TBL] [Abstract][Full Text] [Related]